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The wrong image was used in Figure 5 on page 719. 
The correct figure is presented below:
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Figure  5  effect  of  treatment  with  silicon  dioxide  nanoparticles  on  expression  of 
nicotinamide  adenine  dinucleotide  (NADh)  dehydrogenase  subunit  6  in  human 
astrocytoma U87 cells. U87 cells were treated at specified concentrations of silicon 
dioxide nanoparticles for 48 hours. Then cell lysates of treated and untreated (ie, control) 
u87 cells were prepared as described in Materials and methods. The expression of NADh 
dehydrogenase subunit 6, encoded by mitochondrial DNA, was determined by Western 
blot analysis using β-actin as the loading control: Lane 1, lysate of untreated or control 
u87 cells; lane 2, lysate of u87 cells treated with silicon dioxide nanoparticles at 25 µg/mL;   
lane 3, lysate of u87 cells treated with silicon dioxide nanoparticles at 50 µg/mL; lane 
4, lysate of u87 cells treated with silicon dioxide nanoparticles at 100 µg/mL. The blots 
were from a typical experiment. Two other experiments yielded essentially the same 
trend of results.